The Pharmacogenomics Journal - Table of Contents alert Volume 16 Issue 3

If you are unable to see the message below, click here to view.

Advertisement BioPharma Dealmakers  A supplement to Nature Biotechnology & Nature Reviews Drug Discovery Sign up to our NEW networking forum to connect with life sciences companies and partnering professionals looking for dealmaking opportunities.  Stay up to date on emerging therapeutic areas  Ask for advice from our editors and experts in the field SIGN UP NOW TABLE OF CONTENTS Volume 16, Issue 3 (June 2016) In this issue Review Original Articles Corrigendum Also new AOP Advertisement   THE GENOMICS OF COMMON DISEASES 2016 Presented by Nature Genetics in association with the Wellcome Trust September 25-28, 2016 Renaissance Baltimore Harborplace Hotel | Baltimore, MD, USA REGISTER NOW! Sign up for e-alerts Recommend to your library Web feed Subscribe   Review Top Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation N K Loganadan, H Z Huri, S R Vethakkan and Z Hussein Pharmacogenomics J 2016 16: 209-219; advance online publication, January 26, 2016; 10.1038/tpj.2015.95 Abstract | Full Text Original Articles Top CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors X Wang, G Wang, J Shi, J Aa, R Comas, Y Liang and H-J Zhu Pharmacogenomics J 2016 16: 220-230; advance online publication, June 16, 2015; 10.1038/tpj.2015.42 Abstract | Full Text A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough OPEN J D Mosley, C M Shaffer, S L Van Driest, P E Weeke, Q S Wells, J H Karnes, D R Velez Edwards, W-Q Wei, P L Teixeira, L Bastarache, D C Crawford, R Li, T A Manolio, E P Bottinger, C A McCarty, J G Linneman, M H Brilliant, J A Pacheco, W Thompson, R L Chisholm, G P Jarvik, D R Crosslin, D S Carrell, E Baldwin, J Ralston, E B Larson, J Grafton, A Scrol, H Jouni, I J Kullo, G Tromp, K M Borthwick, H Kuivaniemi, D J Carey, M D Ritchie, Y Bradford, S S Verma, C G Chute, A Veluchamy, M K Siddiqui, C N A Palmer, A Doney, S H MahmoudPour, A H Maitland-van der Zee, A D Morris, J C Denny and D M Roden Pharmacogenomics J 2016 16: 231-237; advance online publication, July 14, 2015; 10.1038/tpj.2015.51 Abstract | Full Text The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis M Fabris, L Quartuccio, C Fabro, S Sacco, S Lombardi, R Ramonda, D Biasi, D Punzi, S Adami, I Olivieri, F Curcio and S De Vita Pharmacogenomics J 2016 16: 238-242; advance online publication, July 7, 2015; 10.1038/tpj.2015.49 Abstract | Full Text Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial Y J He, S J Winham, J M Hoskins, S Glass, J Paul, R Brown, A Motsinger-Reif and H L McLeod for the Scottish Gynaecological Cancer Clinical Trials Group Pharmacogenomics J 2016 16: 243-248; advance online publication, July 21, 2015; 10.1038/tpj.2015.52 Abstract | Full Text Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis L E Salnikova and D S Kolobkov Pharmacogenomics J 2016 16: 249-265; advance online publication, June 30, 2015; 10.1038/tpj.2015.46 Abstract | Full Text Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study E Boldrin, E Rumiato, M Fassan, M Rugge, M Cagol, D Marino, V Chiarion-Sileni, A Ruol, M Gusella, F Pasini, A Amadori and D Saggioro Pharmacogenomics J 2016 16: 266-271; advance online publication, June 9, 2015; 10.1038/tpj.2015.41 Abstract | Full Text AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin J B Kjersem, M Thomsen, T Guren, J Hamfjord, G Carlsson, B Gustavsson, T Ikdahl, G Indrebø, P Pfeiffer, O Lingjærde, K M Tveit, Y Wettergren and E H Kure Pharmacogenomics J 2016 16: 272-279; advance online publication, August 11, 2015; 10.1038/tpj.2015.54 Abstract | Full Text NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD Y Kakuta, T Naito, M Onodera, M Kuroha, T Kimura, H Shiga, K Endo, K Negoro, Y Kinouchi and T Shimosegawa Pharmacogenomics J 2016 16: 280-285; advance online publication, June 16, 2015; 10.1038/tpj.2015.43 Abstract | Full Text CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy A Ortega-Vázquez, P Dorado, I Fricke-Galindo, H Jung-Cook, N Monroy-Jaramillo, I E Martínez-Juárez, I Familiar-López, E Peñas-Lledó, A LLerena and M López-López Pharmacogenomics J 2016 16: 286-292; advance online publication, June 30, 2015; 10.1038/tpj.2015.45 Abstract | Full Text Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms S Mas, P Gassó, D Boloc, N Rodriguez, F Mármol, J Sánchez, M Bernardo and A Lafuente Pharmacogenomics J 2016 16: 293-300; advance online publication, June 30, 2015; 10.1038/tpj.2015.48 Abstract | Full Text Corrigendum Top Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner E Theusch, K Kim, K Stevens, J D Smith, Y-DI Chen, J I Rotter, D A Nickerson and M W Medina Pharmacogenomics J 2016 16: 301; 10.1038/tpj.2016.30 Full Text Advertisement Nature Partner Journals: a new home for your research Over the last two years we have collaborated with over 20 internationally renowned partner organizations to publish cutting-edge open articles in disciplines covering all aspects of research science. Visit our interactive timeline to explore the Nature Partner Journals series and our highlights and milestones so far.      Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.